Tag: Therapy & Procedures: Misc.
PFS Prolonged With Continuous Dabrafenib, Trametinib in Melanoma
Median PFS longer with continuous versus intermittent treatment, but overall survival similar
USPSTF: Behavioral Interventions Likely Prevent Tobacco Use
Primary care-feasible behavioral interventions have moderate net benefit for school-aged children
Adding High-Dose Chloroquine Not Advised for Severe COVID-19
High-dose versus low-dose group had higher lethality until day 13, more instances of QTc interval >500 ms
Expert Panel: There Are No Proven Drug Treatments for COVID-19
Whenever possible, drugs should be given to COVID-19 patients as part of a clinical trial
Physicians Report Expanding Use of Off-Label COVID-19 Treatments
Hydroxychloroquine usage increasing rapidly, although plasma from recovered patients perceived as more effective
Convalescent Plasma Treatment Promising in Severe COVID-19
One dose of CP with neutralizing antibodies can reduce viral load, tends to improve clinical symptoms
Test for COVID-19 Antibodies Approved by FDA
Test checks for protective antibodies in a finger prick of blood
Phone-Based Therapy Beneficial for Depression in Parkinson Disease
Telephone CBT outperformed treatment-as-usual on all depression, anxiety, quality-of-life measures
FDA Eases Access to Blood Plasma Treatment for COVID-19 Patients
Patients receive injections of blood plasma taken from people who have recovered
Per-Capita Medical Radiation Exposure Down in United States
2006 to 2016 saw drop in annual individual effective dose from diagnostic, interventional procedures
